Last Updated on October 11, 2024 by The Health Master
New Delhi: A total of 7,700 samples of drugs were declared not of standard quality (NSQ) and another 670 were declared spurious or adulterated out of a total of 84,874 samples picked for testing during the last three years.
The government data disclosed that a total of 2,652 samples of drugs were declared not of standard quality and 263 were declared spurious or adulterated out of a total of 84,874 samples picked for testing during the years 2020–21.
The enforcement actions were carried out in terms of samples tested. A number of drug samples were declared sub-standard and spurious/adulterated during the last three years.
While 164 persons were arrested as the concerned authority initiated prosecutions in the year 2020-21, over 500 such arrests were made in the last three years.
In a reply in the Lok Sabha on Friday, the Ministry of Health and Family Welfare said that the manufacture, sale, and distribution of drugs in the country are regulated under the provisions of the Drugs & Cosmetics Act, 1940 and Rules, 1945.
Also read the drug alert list, month-wise and year-wise, click below link:
The regulatory control over the manufacture, sale, and distribution of drugs in the country is exercised through a system of licensing and inspection by the State Licensing Authorities (SLAs) appointed by respective State Governments.
The SLAs are legally empowered to take action in case of violation of the condition of the Licence.
The government has taken measures, including strengthening legal provisions, workshops and training programs for manufacturers and regulatory officials, and measures such as risk-based inspection.
In cases of fake and spurious drugs, various enforcement actions like drug seizure, arrests of accused persons/registration of FIR, etc., have been carried out by the states/UTs Drugs Controllers.
The Central Drugs Standard Control Organisation (CDSCO) and the Union Ministry of Health and Family Welfare have taken various regulatory measures to ensure the quality of drugs distributed in the country.
The Drugs and Cosmetics Act, 1940 was amended under the Drugs and Cosmetics (Amendment) Act 2008 to provide stringent penalties for the manufacture of spurious and adulterated drugs.
Certain offenses have also been made cognizable and non-bailable.
Besides, the states/union territories were requested to set up special courts for the trial of offenses under the Drugs and Cosmetics Act for speedy disposal. So far, 33 states have already set up designated special courts.
USFDA gives nod for generic birth control pills
New technology that deactivates COVID-19 virus in just 1 minute
Foreign MBBS holders: Registration only after 2 Years internship: NMC
USFDA gives nod for Belimumab to treat Paediatric Patients
CDSCO issues alert on Blood Purification Device hemoperfusion cartridge
CDSCO gives nod to make generic version of Pfizer’s Covid-19 pill
Norms for small Pharmaceutical firms may be eased
Govt invites applications to produce Vitamin B1
Govt plans to reduce the prices of critical drugs on August 15
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
